版主： 牛河梁
GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at a cash price of $499 per month.
The partnership comes as telehealth and digital health platforms are increasingly viewed as ways to provide greater access to the in-demand products.
本来Novo Nordisk的减肥药，是有HIMS卖，结果HIMS不老实，同时卖仿制药，被Novo Nordisk终止合同。
现在Novo Nordisk改和GDRX合作。应该还有上升空间。
Crocodile 写了： 2025年 8月 18日 12:08GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at a cash price of $499 per month.
The partnership comes as telehealth and digital health platforms are increasingly viewed as ways to provide greater access to the in-demand products.
@Crocodile
大赞分享！多谢
